Report of an abscopal effect induced by stereotactic body radiotherapy and nivolumab in a patient with metastatic non-small cell lung cancer

por Britschgi, Christian, Riesterer, Oliver, Burger, Irene A., Guckenberger, Matthias, Curioni-Fontecedro, Alessandra
Publicado 2018

Colorectal cancer cells display chaperone dependency for the unconventional prefoldin URI1

por Lipinski, Kamil Andrzej, Britschgi, Christian, Schrader, Karen, Christinat, Yann, Frischknecht, Lukas, Krek, Wilhelm
Publicado 2016

Severe reaction to radiotherapy provoked by hypomorphic germline mutations in ATM (ataxia–telangiectasia mutated gene)

por Asadollahi, Reza, Britschgi, Christian, Joset, Pascal, Oneda, Beatrice, Schindler, Detlev, Meier, Urs R., Rauch, Anita
Publicado 2020

BRAF inhibition sensitizes melanoma cells to α-amanitin via decreased RNA polymerase II assembly

por Frischknecht, Lukas, Britschgi, Christian, Galliker, Patricia, Christinat, Yann, Vichalkovski, Anton, Gstaiger, Matthias, Kovacs, Werner J., Krek, Wilhelm
Publicado 2019

MTPpilot: An Interactive Software for Visualization of Next-Generation Sequencing Results in Molecular Tumor Boards

por Kahraman, Abdullah, Arnold, Fabian M., Hanimann, Jacob, Nowak, Marta, Pauli, Chantal, Britschgi, Christian, Moch, Holger, Zoche, Martin
Publicado 2022

Structure-based prediction of BRAF mutation classes using machine-learning approaches

por Krebs, Fanny S., Britschgi, Christian, Pradervand, Sylvain, Achermann, Rita, Tsantoulis, Petros, Haefliger, Simon, Wicki, Andreas, Michielin, Olivier, Zoete, Vincent
Publicado 2022

Mutational Landscape and Expression of PD-L1 in Patients with Non-Small Cell Lung Cancer Harboring Genomic Alterations of the MET gene

por Fischer, Alessa, Bankel, Lorenz, Hiltbrunner, Stefanie, Rechsteiner, Markus, Rüschoff, Jan H., Rushing, Elisabeth Jane, Britschgi, Christian, Curioni-Fontecedro, Alessandra
Publicado 2022

Molecular and immunophenotypic characterization of SMARCB1 (INI1) - deficient intrathoracic Neoplasms

por Haberecker, Martina, Bühler, Marco Matteo, Mendieta, Alicia Pliego, Guggenberger, Roman, Arnold, Fabian, Markert, Eva, Rechsteiner, Markus, Zoche, Martin, Britschgi, Christian, Pauli, Chantal
Publicado 2022

Comprehensive Statistical Exploration of Prognostic (Bio-)Markers for Responses to Immune Checkpoint Inhibitor in Patients with Non-Small Cell Lung Cancer

por Hiltbrunner, Stefanie, Spohn, Meta-Lina, Wechsler, Ramona, Akhoundova, Dilara, Bankel, Lorenz, Kasser, Sabrina, Bihr, Svenja, Britschgi, Christian, Maathuis, Marloes H., Curioni-Fontecedro, Alessandra
Publicado 2021

When SUV Matters: FDG PET/CT at Baseline Correlates with Survival in Soft Tissue and Ewing Sarcoma

por Hack, Ruben I., Becker, Anton S., Bode-Lesniewska, Beata, Exner, G. Ulrich, Müller, Daniel A., Ferraro, Daniela A., Warnock, Geoffrey I., Burger, Irene A., Britschgi, Christian
Publicado 2021

Temporal activation of WNT/β-catenin signaling is sufficient to inhibit SOX10 expression and block melanoma growth

por Uka, Rexhep, Britschgi, Christian, Krättli, Anja, Matter, Claudia, Mihic, Daniela, Okoniewski, Michal J., Gualandi, Marco, Stupp, Roger, Cinelli, Paolo, Dummer, Reinhard, Levesque, Mitchell P., Shakhova, Olga
Publicado 2020

Real-World Treatment Patterns and Survival Outcome in Advanced Anaplastic Lymphoma Kinase (ALK) Rearranged Non-Small-Cell Lung Cancer Patients

por Britschgi, Christian, Addeo, Alfredo, Rechsteiner, Markus, Delaloye, Raphaël, Früh, Martin, Metro, Giulio, Banini, Marco, Gautschi, Oliver, Rothschild, Sacha I., Wild, Peter J., Banna, Giuseppe L., Curioni-Fontecedro, Alessandra
Publicado 2020

ROS1 genomic rearrangements are rare actionable drivers in microsatellite stable colorectal cancer

por Akhoundova, Dilara, Hussung, Saskia, Sivakumar, Smruthy, Töpfer, Antonia, Rechsteiner, Markus, Kahraman, Abdullah, Arnold, Fabian, Angst, Florian, Britschgi, Christian, Zoche, Martin, Moch, Holger, Weber, Achim, Sokol, Ethan, Fritsch, Ralph M.
Publicado 2022

Establishment of an Academic Tissue Microarray Platform as a Tool for Soft Tissue Sarcoma Research

por Lee, Che-Jui, Wozniak, Agnieszka, Van Cann, Thomas, Timmermans, Iris, Wellens, Jasmien, Vanleeuw, Ulla, Briaire-de Bruijn, Inge H., Britschgi, Christian, Bovée, Judith V. M. G., Zlobec, Inti, Sciot, Raf, Schöffski, Patrick
Publicado 2021

Patient recruitment into clinical studies of solid malignancies during the COVID-19 pandemic in a tertiary cancer center

por von der Grün, Jens, Ahmadsei, Maiwand, Breyer, Isabel, Britschgi, Christian, Eberli, Daniel, Hermanns, Thomas, Mangana, Joanna, Petrowsky, Henrik, Ramelyte, Egle, Roth, Patrick, Schär, Gabriel, Opitz, Isabelle, Weller, Michael, Wicki, Andreas, Witzel, Isabell, Balermpas, Panagiotis, Guckenberger, Matthias
Publicado 2023

Unravelling homologous recombination repair deficiency and therapeutic opportunities in soft tissue and bone sarcoma

por Planas‐Paz, Lara, Pliego‐Mendieta, Alicia, Hagedorn, Catherine, Aguilera‐Garcia, Domingo, Haberecker, Martina, Arnold, Fabian, Herzog, Marius, Bankel, Lorenz, Guggenberger, Roman, Steiner, Sabrina, Chen, Yanjiang, Kahraman, Abdullah, Zoche, Martin, Rubin, Mark A, Moch, Holger, Britschgi, Christian, Pauli, Chantal
Publicado 2023

Safety of Tepotinib in Patients With MET Exon 14 Skipping NSCLC and Recommendations for Management

por Veillon, Remi, Sakai, Hiroshi, Le, Xiuning, Felip, Enriqueta, Cortot, Alexis B., Smit, Egbert F., Park, Keunchil, Griesinger, Frank, Britschgi, Christian, Wu, Yi-Long, Melosky, Barbara, Baijal, Shobhit, de Castro, Gilberto, Sedova, Michaela, Berghoff, Karin, Otto, Gordon, Paik, Paul K.
Publicado 2022

Outcome and Prognostic Factors of COVID-19 Infection in Swiss Cancer Patients: Final Results of SAKK 80/20 (CaSA)

por Joerger, Markus, Metaxas, Yannis, Zaman, Khalil, Michielin, Olivier, Mach, Nicolas, Bettini, Adrienne, Schmitt, Andreas M., Cantoni, Nathan, Caspar, Clemens B., Stettler, Sonja, Malval, Roma, Pless, Miklos, Britschgi, Christian, Renner, Christoph, Koeberle, Dieter, Schulz, Jessica D., Kopp, Christoph, Hayoz, Stefanie, Stathis, Anastasios, von Moos, Roger
Publicado 2022

Tepotinib Efficacy and Safety in Patients with MET Exon 14 Skipping NSCLC: Outcomes in Patient Subgroups from the VISION Study with Relevance for Clinical Practice

por Le, Xiuning, Sakai, Hiroshi, Felip, Enriqueta, Veillon, Remi, Garassino, Marina Chiara, Raskin, Jo, Cortot, Alexis B., Viteri, Santiago, Mazieres, Julien, Smit, Egbert F., Thomas, Michael, Iams, Wade T., Cho, Byoung Chul, Kim, Hye Ryun, Yang, James Chih-Hsin, Chen, Yuh-Min, Patel, Jyoti D., Bestvina, Christine M., Park, Keunchil, Griesinger, Frank, Johnson, Melissa, Gottfried, Maya, Britschgi, Christian, Heymach, John, Sikoglu, Elif, Berghoff, Karin, Schumacher, Karl-Maria, Bruns, Rolf, Otto, Gordon, Paik, Paul K.
Publicado 2022